These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9450770)

  • 1. Association of IgM type anti-GM1 antibodies and muscle strength in chronic acquired demyelinating polyneuropathy.
    Bech E; Andersen H; Orntoft TF; Jakobsen J
    Ann Neurol; 1998 Jan; 43(1):72-8. PubMed ID: 9450770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-ganglioside antibodies in peripheral neuropathy.
    McCombe PA; Wilson R; Prentice RL
    Clin Exp Neurol; 1992; 29():182-8. PubMed ID: 1343861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibodies to GM1 ganglioside in motor neuron disease--in comparison with demyelinating neuropathy].
    Irie S; Saito T; Ogino M; Ito H; Kowa H
    Rinsho Shinkeigaku; 1992 Oct; 32(10):1075-80. PubMed ID: 1297550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
    Irie S; Saito T; Kanazawa N; Ito H; Kowa H
    Rinsho Shinkeigaku; 1994 May; 34(5):454-60. PubMed ID: 7924057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of anti-GM1 IgM antibodies.
    Nobile-Orazio E; Carpo M; Scarlato G
    Acta Neurol (Napoli); 1991 Dec; 13(6):514-9. PubMed ID: 1805551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do GM1 antibodies induce demyelination?
    Lange DJ; Trojaborg W
    Muscle Nerve; 1994 Jan; 17(1):105-7. PubMed ID: 8264688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
    Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
    Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demyelinating symmetric motor polyneuropathy with high titers of anti-GM1 antibodies.
    O'Ferrall EK; White CM; Zochodne DW
    Muscle Nerve; 2010 Oct; 42(4):604-8. PubMed ID: 20730877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of chronic inflammatory demyelinating polyneuropathy with recurrent ophthalmoplegia, persistent conduction block, antibody activity against gangliosides GM1].
    Ryo M; Saito T; Kunii N; Hasegawa H; Kowa H
    Rinsho Shinkeigaku; 1994 Jul; 34(7):702-6. PubMed ID: 7955728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of testing for anti-GM1 antibodies.
    McCombe PA; Wilson R; Prentice RL
    J Clin Neurosci; 2000 May; 7(3):209-12. PubMed ID: 10833617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-GM1 antibodies in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg).
    van Schaik IN; Vermeulen M; van Doorn PA; Brand A
    J Neuroimmunol; 1994 Oct; 54(1-2):109-15. PubMed ID: 7929799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
    Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
    J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis and neuropathies.
    Lamb NL; Patten BM
    Muscle Nerve; 1991 Oct; 14(10):1021-7. PubMed ID: 1944401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-GM1 and anti-sulphatide antibodies in systemic idiopathic vasculitis, systemic lupus erythematosus and mixed cryoglobulinaemia: Serum detection and clinical and electrophysiologic correlations].
    Alpa M; Ferrero B; Cavallo R; Naretto C; Gennaro M; Bellizia L; Sena LM; Roccatello D
    G Ital Nefrol; 2002; 19(6):617-21. PubMed ID: 12508165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
    J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls.
    Uetz-von Allmen E; Sturzenegger M; Rieben R; Rihs F; Frauenfelder A; Nydegger UE
    Eur Neurol; 1998; 39(2):103-10. PubMed ID: 9520071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-GM1 gangliosides antibodies in multifocal motor neuropathies].
    Younes-Chennoufi AB; Baumann N
    Rev Neurol (Paris); 1996 May; 152(5):375-9. PubMed ID: 8881433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.